The intended purpose of machine learning (ML) in cardiovascular medicine is to help guide clinical diagnoses as well as promote scientific discovery. Whether ML is implemented by most clinical cardiologists and cardiovascular researchers will likely depend on the successful resolution of concerns fueling hesitancy to embrace ML. This commentary discusses caveats related to ML in clinical practice, and offers suggestions for stakeholders on how to bridge knowledge gaps and clinicians’ misgivings to bring this powerful approach to the clinic to improve care of the patients we serve.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Benjamens, S., Dhunnoo, P. & Meskó, B. npj Digit. Med. 3, 118 (2020).
Zekavat, S. M. et al. Circulation 145, 134–150 (2022).
Zech, J. R. et al. PLoS Med. 15, e1002683 (2018).
Reardon, S. Nature 576, S54–S58 (2019).
Huisman, M. et al. Eur. Radiol. 31, 7058–7066 (2021).
Nikpay, M. et al. Nat. Genet. 47, 1121–1130 (2015).
Pattarabanjird, T. et al. Genes 11, 1446 (2020).
Ridker, P. M. et al. N. Engl. J. Med. 377, 1119–1131 (2017).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Pattarabanjird, T., McNamara, C. The clinicians’ perspectives on machine learning. Nat Cardiovasc Res 1, 189–190 (2022). https://doi.org/10.1038/s44161-022-00033-9
Published:
Issue Date:
DOI: https://doi.org/10.1038/s44161-022-00033-9